The following is an updated article about the study completed by 8 PwP.
It gives you a summary of the biological processes, the first results and what the high response symptoms may be telling us about the mechanisms involved. I am still waiting for detailed statistical analysis and for further feedback from Prof Jed Fahey. Finally I make a suggestion about what I think should be done next. There is little point in just repeating the same experiment with a few more people. The next trial has to be done better, much better... with more professionalism, proper chemical and clinical analysis and more rigour. That is going to cost money ....
It's here
I'm a big fan of sulforaphane's role in Nrf2 activation. The few things people need to watch out for is the possibility of iodine deficiency (supplement Lugol's at alternate times not being deficient on selenium) and being sure that molybdenum-dependent detox enzymes aren't underperforming not to experience sulfite related toxicity (or sulfate deficiency blocking sulfation pathway) - build up very slowly and not be deficient in molybdenum and methyl donors.